Table 2 of Verma, Mol Vis 2025; 31:55-67.


Table 2. In silico analysis of identified LTBP2 variants.

Variant No. LTBP2 cDNA variant LTBP2 protein variant Variant chromosomal location Variation impact Franklin prediction Mutation taster prediction PhyloP Phast Cons Potential target for NMD (Y/N) Potential effect on splicing (Y/N) MutPred 2 CADD_ phred Score
1 c.3499C>T p.Gln1167Ter 14:74508857-74508857 STOPGAIN at 1167 aa LP Disease causing 2.241 1 Y No 0.83405 41
2 c.3183C>A p.Cys1061Ter 14:74509828-74509828 STOPGAIN at 1061 aa LP Disease causing 3.18 1 Y Y 0.80611 36
3 c.328C>T p.Gln110Ter 14:74611617-74611617 STOPGAIN at 110 aa LP Disease causing 0.237 0.982 Y Y 0.64702 37
4 c.1921del p.Arg641GlyfsTer101 14:74532491-74532492 FS at Arg causing PSC at 101 aa downstream LP Disease causing 2.643 1 Y Y 0.683 NA
5 c.1756dupG p.Val586GlyfsTer17 14:74549896-74549896 FS at Val-586 replaced by Gly causing PSC at 17 aa downstream LP Disease causing 3.067 0.418 Y N 0.537 NA
6 c.985C>T p.Gln329Ter 14:74555539-74555539 STOPGAIN at 329 aa LP Disease causing 0.538 0.305 Y Y 0.78926 38
7 c.4237T>G p.Cys1413Gly 14:74505115-74505115 Substitution of Cys with Gly at 1413 aa VUS Disease causing 5.65 1 N N 0.51 26.3
8 c.1201dupC p.Gln401ProfsTer202 14:74552385-74552385 FS at Gln-401 replaced by Pro causing PSC at 202 aa downstream LP Disease causing 2.59 1 Y N 0.905 NA
9 c.3131C>G p.Ser1044Ter 14:74510111-74510111 STOPGAIN at 1044 aa LP Disease causing -0.458 0.119 Y Y 0.80079 36
10 c.4171dupG p.Ala1391GlyfsTer8 14:74506054-74506054 FS at Ala-1391replaced by Gly causing PSC at 8aa downstream LP Disease causing 0.693 0.283 Y N 0.101 NA
11 c.4545_4552del p.Gly1516LeufsTer9 14:74503955-74503963 FS at Gly 1516 replaced by Leu causing PSC at 9 aa downstream LP Disease causing 0.26 0.999 Y N 0.956 NA
12 c.2811del p.Val939CysfsTer71 14:74516918-74516919 FS at Val-939 replaced by Cys causing PSC at 71 aa downstream LP Disease causing 0.579 0.001 Y Y 0.468 NA